Internal Medicine, Infectious Disease · Sebastian, FL
NPI
1619153541
Since 2008
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
7955 Bay St, Suite 2
Sebastian, FL, 32958
Phone (772) 388-9155
Groups this clinician bills Medicare through
Medicare paid, 2024
$177K
2,883 services
Medicare patients, 2024
320
Average age 76
Drug cost, 2024
$2.5M
2,462 prescriptions
Company payments, 2025
$1,441
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Aisha Q Thomas-St. Cyr was code 99232 (hospital e&m - subsequent), 554 times for 155 patients. In total Aisha Q Thomas-St. Cyr billed 2,883 services in 37 codes, and Medicare paid $177K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-01-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 554 | 155 | $62.57 | $35K |
| 99214 Office E&M - Established | Office | 281 | 118 | $98.74 | $28K |
| 99213 Office E&M - Established | Office | 199 | 81 | $72.00 | $14K |
| 99215 Office E&M - Established | Office | 161 | 26 | $140.54 | $23K |
| J7050 Infusion, normal saline solution, 250 cc | Office | 152 | 23 | $0.52 | $78.52 |
| 96365 Intravenous Infusion, Hydration | Office | 151 | 23 | $49.18 | $7,427 |
| 99233 Hospital E&M - Subsequent | Facility | 128 | 36 | $94.79 | $12K |
| 99222 Hospital E&M - Initial | Facility | 123 | 117 | $101.09 | $12K |
| 99223 Hospital E&M - Initial | Facility | 91 | 80 | $137.29 | $12K |
| 99214 Office E&M - Established | Facility | 84 | 13 | $74.78 | $6,281 |
| 99204 Office E&M - New | Office | 57 | 57 | $130.82 | $7,457 |
| 99231 Hospital E&M - Subsequent | Facility | 19 | 18 | $40.12 | $762 |
| 36415 Venipuncture Blood Collection | Office | 19 | 12 | $8.65 | $164 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 12 | 11 | $42.81 | $514 |
By year: 2022 $261K for 4,230 services; 2023 $209K for 3,314 services; 2024 $177K for 2,883 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 19 | 12 | $8.65 | $164 |
Medicare prescription drug claims, 2024
In 2024, the drug Aisha Q Thomas-St. Cyr prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 206 prescriptions and refills. In total Aisha Q Thomas-St. Cyr wrote 2,462 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 206 | 206 | 22 | $771K |
| Gabapentin Generic | 73 | 73 | Under 11 | $742 |
| Atorvastatin Calcium Generic | 70 | 70 | Under 11 | $217 |
| Juluca Dolutegravir/Rilpivirine | 65 | 65 | Under 11 | $215K |
| Dovato Dolutegravir Sodium/Lamivudine | 55 | 55 | Under 11 | $151K |
| Omeprazole Generic | 55 | 59 | Under 11 | $357 |
| Descovy Emtricitabine/Tenofov Alafenam | 53 | 53 | Under 11 | $101K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 52 | 58 | Under 11 | $259 |
| Valacyclovir Valacyclovir Hcl | 50 | 58 | 12 | $504 |
| Mupirocin Generic | 50 | 52 | 22 | $360 |
| Ketoconazole Generic | 49 | 49 | Under 11 | $632 |
| Prezcobix Darunavir/Cobicistat | 46 | 46 | Under 11 | $99K |
| Metformin Hcl Generic | 45 | 53 | Under 11 | $236 |
| Ceftriaxone Ceftriaxone Sodium | 43 | 43 | 14 | $5,759 |
| Doxycycline Hyclate Generic | 39 | 43 | 22 | $407 |
Brand drugs: - claims; generic drugs: 1,648 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Aisha Q Thomas-St. Cyr $1,441 ($1,441 in general payments such as food, travel and fees) from 6 companies. The largest payer was Gilead Sciences, Inc. with $592.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.